PRKRA expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.24230003851045E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.09030000028376E-07 |
Normal-vs-Stage2 |
1.303990E-03 |
Normal-vs-Stage3 |
9.87099999516516E-08 |
Normal-vs-Stage4 |
2.059699999446E-08 |
Stage1-vs-Stage2 |
7.846200E-01 |
Stage1-vs-Stage3 |
1.973420E-01 |
Stage1-vs-Stage4 |
1.337400E-01 |
Stage2-vs-Stage3 |
2.940600E-01 |
Stage2-vs-Stage4 |
2.289600E-01 |
Stage3-vs-Stage4 |
7.849000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.7626000043135E-08 |
Normal-vs-AfricanAmerican |
9.2222000036557E-08 |
Normal-vs-Asian |
8.238600E-03 |
Caucasian-vs-AfricanAmerican |
3.266800E-01 |
Caucasian-vs-Asian |
6.232800E-01 |
AfricanAmerican-vs-Asian |
8.039200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.32480004744195E-09 |
Normal-vs-Female |
3.21729999996911E-06 |
Male-vs-Female |
5.080300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.56629999995095E-06 |
Normal-vs-Age(41-60Yrs) |
2.32690000045999E-07 |
Normal-vs-Age(61-80Yrs) |
2.39520000500093E-08 |
Normal-vs-Age(81-100Yrs) |
6.544600E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.350790E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.824150E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.427250E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.630200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.327600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.280200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.397800E-02 |
Normal-vs-Grade 2 |
2.44640000000018E-05 |
Normal-vs-Grade 3 |
1.84696702376641E-12 |
Normal-vs-Grade 4 |
1.63159996624529E-09 |
Grade 1-vs-Grade 2 |
9.387200E-01 |
Grade 1-vs-Grade 3 |
2.166600E-01 |
Grade 1-vs-Grade 4 |
1.908610E-01 |
Grade 2-vs-Grade 3 |
3.142500E-03 |
Grade 2-vs-Grade 4 |
8.183900E-03 |
Grade 3-vs-Grade 4 |
6.602200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.73010000000096E-05 |
Normal-vs-ccB subtype |
6.38439999756102E-08 |
ccA subtype-vs-ccB subtype |
3.900100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.89049999987922E-07 |
Normal-vs-N1 |
2.31759999999026E-05 |
N0-vs-N1 |
1.552990E-01 |
|
|